Anti-Human TSLP Reference Antibody (Ecleralimab, RUO) (HV243026)

Name: Anti-Human TSLP Reference Antibody (Ecleralimab, RUO)
Brand: abinScience
SKU: HV243026
Price: 176 USD
Availability: InStock

Fiche technique Partager le produit Copier les informations

Prix(USD) :

Spécification :

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Nombre :

Contactez-nous

Aperçu
Images
Reférences
Fiche technique
SDS

Aperçu

Numéro de catalogue	HV243026
Description	Ecleralimab (HV243026) is a research-grade recombinant antibody targeting TSLP. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactivité des espèces	Human
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Espèce hôte	Human
Clonalité	Monoclonal
Isotype	IgG1- lambda
Système d'expression	Mammalian cells
Cible	TSLP, Thymic stromal lymphopoietin
Niveau d'endotoxines	< 10 EU/mg
Pureté	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Numéro d'accès	Q969D9
Forme	Liquid
Tampon de stockage	0.01M PBS pH 7.4 Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.
Stabilité et stockage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Noms alternatifs	2415207-91-7, CSJ117, CSJ-117, NVP-CSJ117, NOV-14, CSJ117
Contexte	Thymic stromal lymphopoietin (TSLP) is a ~18 kDa protein. Cytokine that induces the release of T-cell-attracting chemokines from monocytes and, in particular, enhances the maturation of CD11c(+) dendritic cells. Can induce allergic inflammation by directly activating mast cells.
Note	For research use only. Not suitable for clinical or therapeutic use.